Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

100%(2 trials)

Phase Distribution

Ph phase_3

25%

Ph not_applicable

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Recruiting2

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

recruiting250%

completed250%

Recent Activity

2 active trials

Showing 4 of 4

completednot_applicable

Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes

NCT04955691

recruitingnot_applicable

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

NCT03710928

recruitingnot_applicable

Effects of Ketosis on Brain Function in Patients With T1DM

NCT04219709

completedphase_3

Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

NCT04460326

Clinical Trials (4)

Showing 4 of 4 trials

NCT04955691Not Applicable

Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes

Completed

NCT03710928Not Applicable

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

Recruiting

NCT04219709Not Applicable

Effects of Ketosis on Brain Function in Patients With T1DM

Recruiting

NCT04460326Phase 3

Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

Completed

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4